Cholangiocarcinoma: State-of-the-art knowledge and challenges
Liver Int
.
2019 May:39 Suppl 1:5-6.
doi: 10.1111/liv.14101.
Authors
Jesus M Banales
1
,
Vincenzo Cardinale
2
,
Rocio I R Macias
3
,
Jesper B Andersen
4
,
Chiara Braconi
5
,
Guido Carpino
6
,
Domenico Alvaro
7
,
Diego F Calvisi
8
Affiliations
1
Department on Liver and Gastrointestinal Diseases, Biodonostia Research Institute, University of the Basque Country, San Sebastian, Spain.
2
Department of Medico-Surgical Sciences and Biotechnologies, Sapienza University of Rome, Rome, Italy.
3
Experimental Hepatology and Drug Targeting, University of Salamanca, IBSAL, Salamanca, Spain.
4
Department of Health and Medical Sciences, Biotech Research and Innovation Centre, University of Copenhagen, Copenhagen N, Denmark.
5
Division of Cancer Therapeutics, The Institute of Cancer Research, London, UK.
6
Department of Movement, Human and Health Sciences, Division of Health Sciences, University of Rome "Foro Italico", Rome, Italy.
7
Department of Translational and Precision Medicine, Sapienza University of Rome, Rome, Italy.
8
Institute of Pathology, University of Regensburg, Regensburg, Germany.
PMID:
31111668
DOI:
10.1111/liv.14101
No abstract available
Publication types
Editorial
MeSH terms
Bile Duct Neoplasms / diagnosis
Bile Duct Neoplasms / genetics*
Cholangiocarcinoma / diagnosis
Cholangiocarcinoma / genetics*
Humans
Grants and funding
RIF2014_01_BRACONI/PANCREATICCANUK_/Pancreatic Cancer UK/United Kingdom